Shares of drug pricing company GoodRx soared on Wednesday, up 53% from its initial IPO list price of $33 at market close. The company best known for its drug discount coupons is also cashing in on the virtual care boom set off by the Covid-19 pandemic through its telemedicine services.
Trending:
GoodRx IPO shows low drug prices can still mean big money